(Q40629471)

English

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list

scientific article published on October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 September 2017

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list (English)

1 reference

Europe PubMed Central

22 September 2017

liver transplantation

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

John P. Roberts

8

object named as

John P Roberts

1 reference

Europe PubMed Central

22 September 2017

7

object named as

Nancy L Ascher

1 reference

Europe PubMed Central

22 September 2017

author name string

Francis Y Yao

1

1 reference

Europe PubMed Central

22 September 2017

Nathan M Bass

2

1 reference

Europe PubMed Central

22 September 2017

Bev Nikolai

3

1 reference

Europe PubMed Central

22 September 2017

Timothy J Davern

4

1 reference

Europe PubMed Central

22 September 2017

Robert Kerlan

5

1 reference

Europe PubMed Central

22 September 2017

Victor Wu

6

1 reference

Europe PubMed Central

22 September 2017

publication date

1 October 2002

1 reference

Europe PubMed Central

22 September 2017

Liver Transplantation

1 reference

Europe PubMed Central

22 September 2017

8

1 reference

Europe PubMed Central

22 September 2017

10

1 reference

Europe PubMed Central

22 September 2017

873-883

1 reference

Europe PubMed Central

22 September 2017

Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome.

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Liver transplantation for small hepatocellular carcinoma in cirrhosis: analysis of our experience

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Locoregional management of hepatocellular carcinoma. Surgical and ablation therapies

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization.

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

A model to predict survival in patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

MELD and PELD: application of survival models to liver allocation

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Long-term outcome of patients transplanted with livers from hepatitis C-positive donors

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34923

21 January 2018

Identifiers

10.1053/JLTS.2002.34923

1 reference

Europe PubMed Central

22 September 2017

1 reference

Europe PubMed Central

22 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40629471&oldid=2050700427"